Publication | Closed Access
Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in Stage III and IV ovarian carcinoma
18
Citations
28
References
2000
Year
The combination of paclitaxel, cisplatin, and epirubicin is a well tolerated outpatient regimen with significant activity in the treatment of advanced epithelial ovarian carcinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1